Drug pricing

FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs

Mentioned in the FT. Expensive biologic medications make up only 5% of More

London’s Life Sciences resilience

Merck recently announced its withdrawal from a planned £1bn expansion in King’s More

McDermott Will & Schulte’s HPE NYC, Agenda.

McDermott Will & Schulte’s HPE (Healthcare Private Equity) NYC brings together 600+ More

Oliver Wyman’s Health Innovation Summit.

Oliver Wyman’s Health Innovation Summit was held from 15 to 17 September More

KKR acquires majority stake in HealthCare Royalty Partners

After Partners Group’s move last year, royalty strategies becoming mainstream for one More

The Pharmaceutical Industry in Figures

EFPIA study mentioned in Les Echos

LA SITUATION ETLES PERSPECTIVES DES FINANCES PUBLIQUES

Rapport de la Cour des Comptes cité dans les Echos

Partners Group on royalties

White paper on their website

Royalty Pharma funding Biogen R&D

Royalty Pharma Announces R&D Funding Collaboration With Biogen

Royalty pharma 2024 results

includes transcript and spreadsheet Spreadsheet on royalties

Latest articles

Geopolitics

Scénarios géostratégiques baltes : note de l’Institut Montaigne

Mentionnée notamment par le Monde Rappel de l’article 42 §7 du Traité More

Corporate Venture

Mantra’s Niche Private Equity Index Q4 2025

Published 4 November 2025. Mantra’s Index highlights the niche private equity strategies More

Artificial Intelligence

CB Insights’ State of AI Global Q3 2025

Growing market (#3 by recruitments): Defence & National security AI copilots